Chris Degnan

Chris Degnan

Chief Financial OfficeratUroGen Pharma· In proxies 2023–2024

Pay in FY2024UroGen Pharma stock -29.0% the same year

Chris Degnan was paid $1.1M in FY2024 (Dec). UroGen Pharma stock fell 29.0% that year.

Pay$100 in the stock at the end of FY22 → $120
Pay is from the Summary Compensation Table of each UroGen Pharma proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. UroGen PharmaPublic company · 3 yr
    • Chief Financial Officer2023 – Present · 3 yrStock in role +323%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?